You are on page 1of 2

CAPITOL UNIVERSITY COLLEGE OF NURSING

NAME OF PATIENT: REVACA, BEBIANO

DRUG STUDY
INDICATIONS
Relief of symptoms associated w/ seasonal & persistent allergic rhinitis.

DRUG ORDER
(Generic name, Brand name, Classification, Dosage, Route, Frequency)

MECHANISM OF ACTION
Montelukast inhibits bronchoconstriction due to antigen challenge. Montelukast is a selective leukotriene receptor antagonist of the cysteinyl leukotriene CysLT 1 receptor. The cysteinyl leukotrienes (LTC 4, LTD 4, LTE 4) are products of arachidonic acid metabolism that are released from various cells, including mast cells and eosinophils. They bind to cysteinyl leukotriene receptors (CysLT) found in the human airway.

CONTRAINDICA TIONS
Severe renal (CrCl <10 mL/min) or hepatic impairment. Childn 6-11 yr w/ renal impairment. Pregnancy & lactation.

ADVERSE NURSING EFFECTS OF THE RESPONSIBILITIE DRUG S/ PRECAUTIONS


Asthenia, fatigue, fever, abdominal pain, trauma, dyspepsia, infectious gastroenteritis, dental pain, dizziness, headache, nasal congestion, cough & influenza. Elderly, patients w/ renal impairment

GENERIC NAME:

BRAND NAME: ZYKAST

CLASSIFICATION: Anti-histamine

DOSAGE: Adult & childn >15 yr 1 tab daily.

ROUTE:

FREQUENCY: